What composition of drugs is more efficacious for the suprascapular nerve block given in patients with cervical pain.

Phase 3

• Conditions: Health Condition 1: M501- Cervical disc disorder with radiculopathy

• Registration Number: CTRI/2022/05/042711
• Lead Sponsor: PtBDSharma PGIMS ROHTAK

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients fulfilling following three criteria will be included in the study:

�History, physical examination and pain pattern consistent with cervical radiculopathy.

ââ?¬Â¢X-ray cervical spine or MRI findings corresponding with the patientââ?¬•s clinical symptoms.

�Failure to respond to six weeks of conservative treatment.

Exclusion Criteria

Patients with

�History of uncontrolled diabetes mellitus

�Active infection or active wound at the suprascapular, cervical and upper limb areas.

�Known contraindications to nerve block in suprascapular, neck and shoulder areas

�Recent history of severe trauma to the suprascapular, neck and upper limb

�History of suprascapular nerve block injection in the past three months

�History of allergy or adverse reaction to the injecting agents

�History of severe chronic airway or cardiovascular ir cerebrovascular disease

�History of systemic use of steroid two weeks before the injection

�Ongoing pregnancy or breastfeeding

�Pain in upper limb due to conditions like osteoarthritis, rheumatoid arthritis, frozen shoulder

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary objective: <br/ ><br>To assess pain relief (using numeric rating scale) following the suprascapular nerve block using drug mixture of 0.25% bupivacaine and 8mg dexamethasone with suprascapular nerve block using drug mixture of 0.25% bupivacaine with 4 mg dexamethasone in cervical radicular pain. <br/ ><br>Timepoint: 30 minutes after procedure <br/ ><br>2 weeks after procedure <br/ ><br>1 month after procedure <br/ ><br>2 months after procedure <br/ ><br>3 months after procedure

Secondary Outcome Measures

Name	Time	Method
�To study the patient�s self reported belief about the efficacy of treatment using patient global impression of change (PGIC) scale. <br/ ><br>�To study side effects and complications, if any. <br/ ><br>Timepoint: 2 weeks after the procedure <br/ ><br>1 month after procedure <br/ ><br>3 months after procedure